NUTRA PHARMA CORP. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a3a7637f-370e-4229-b5ef-7c3decaa702b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-2.0M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-024641 |
| FY 2024 | $-1.3M | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-007044 |
| FY 2023 | $-1.4M | 2023-01-01 – 2023-12-31 | evidence 0001493152-25-024800 |
| FY 2022 | $8.2M | 2022-01-01 – 2022-12-31 | evidence 0001641172-25-026446 |
| FY 2021 | $-13.1M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010035 |
| FY 2020 | $-769.2k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-022204 |
| FY 2019 | $-6.6M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-015860 |
| FY 2018 | $-3.9M | 2018-01-01 – 2018-12-31 | evidence 0001398432-21-000007 |
| FY 2017 | $-4.0M | 2017-01-01 – 2017-12-31 | evidence 0001398432-18-000049 |
| FY 2016 | $-3.4M | 2016-01-01 – 2016-12-31 | evidence 0001398432-17-000073 |
| FY 2015 | $-5.4M | 2015-01-01 – 2015-12-31 | evidence 0001398432-16-000597 |
| FY 2014 | $-2.5M | 2014-01-01 – 2014-12-31 | evidence 0001398432-15-000168 |
| FY 2013 | $-4.3M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-019555 |
| FY 2012 | $-3.6M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-022247 |
| FY 2011 | $-4.4M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-063254 |
| FY 2010 | $-3.1M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-063254 |
| FY 2009 | $-2.3M | 2009-01-01 – 2009-12-31 | evidence 0001144204-13-030545 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).